Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.

The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.

Eclipse Ventures

EcoR1 Capital

Skyviews Life Science

Decheng Capital

Willett Advisors LLC

Koch Disruptive Technologies

Bristol-Myers Squibb

DFJ Growth

Cellares

Rodney L Rietze, PhD, Co-Founder and CEO of iVexSol, and Cellares Advisory Board Member, discusses how an Integrated Development Manufacturing Organization's (IDMO) transformative technology seamlessly integrate unit operations and break the bottlenecks of cell therapy manufacturing scalability.

Watch the full video here: https://lnkd.in/gNYwsE3U

ℹ️ Cellares TAP Program is ending soon ℹ️

#IDMO #celltherapymanufacturing
https://lnkd.in/e7Xb8ANt

Watch Timothy Moore, CTO at Allogene Therapeutics and Cellares Advisory Board Member, discuss the constraints of conventional CDMOs and how an Integrated Development and Manufacturing Organization (IDMO) can help the industry scale manufacturing to meet the global patient demand for cell therapies.

Click here to see the full interview:

https://lnkd.in/gzbVQPw7

Cellares’ Series C Fundraising Triumph: Launching A New Smart Factory In Somerset County, NJ

Learn more & get our take 👇
https://lnkd.in/gHcrUnm3

“We’re excited to welcome Cellares to the life sciences hub of New Jersey,” – Shanel Robinson, Commissioner Director at Somerset County

“The opening of this facility marks a tremendous milestone towards Cellares’ mission of accelerating access to life-saving cell therapies to meet total global patient demand,” – John Tomtishen, Sr. Vice President and General Manager at Bridgewater IDMO Smart Factory

“Not only does Cellares join a thriving Life Sciences industry here, but they reinforce the fact that many of the cures needed by the world come from Somerset County,” – Jessica Paolini, Manager of Economic Development at Somerset County

#funding #lifesciences #SoHCNews

Viewport Meta

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

Google Analytics

DNSSEC

Co-Founder & CEO

Fabian Gerlinghaus

Chief Financial Officer

Gary Lo

Co-Founder and President

Omar Kurdi

Vice President of Research & Development

Daniele Malleo

Vice President of Quality

Einav Kraft

Operations

John Tomtishen

Engineering

Wilson Toy

Director, People Operations

Becca Hennessy

Marketing and Product

Connor Anderson

Director of Business Development

Daniel Weinstein

Justin Butler

David M. Mauney

Victor Tong

Co-Founder and CEO

Justin McAnear

Jonathan Butler

General Counsel & Secretary

VP of Operations

San Francisco Bay Area Life Science Companies

Biotechnology Late Stage Companies With Less Than $50M in Revenue

Manufacturing Late Stage Companies With More Than $1M in Revenue

Western US Companies With More Than $1M in Revenue (Top 10K)

Cellares develops the Cell Shuttle, to overcome the challenges associated with manufacturing so these life-saving therapies are affordable and widely available to patients who can benefit.

The clinical impact of cell therapy in treating cancer has been proven, but this therapeutic approach has several limitations, especially in manufacturing, leaving extremely sick patients waiting for treatment and desperate for hope.
Since cell therapy is currently produced for a single patient at a time, it is expensive to manufacture, requiring significant time and resources, and is difficult to scale. 

Preclinical and clinical scientists, as well as commercial cell therapy manufacturers also lack the options to fully automate their manufacturing process quickly, safely, cost-effectively, and at the scale they need.

The Cell Shuttle is an automated and closed end-to-end manufacturing solution that is flexible and scalable, enabling customers to run exact processes specified for their cell therapy. Compared with the current manual manufacturing processes for cell therapy, the Cell Shuttle’s next-generation automated manufacturing solution has 10 times the scalability (meaning 10 times more patient doses can be produced simultaneously), enables a three-fold reduction in process failure rates, and will reduce the per-patient manufacturing cost by up to 70 percent for most processes.

Series C - Cellares

Series B - Cellares

Series A - Cellares

Computer and Software Products and Electrical and Scientific Products

South San Francisco

California

United States

North America

Cellares Appoints Justin McAnear as CFO and Jonathan Butler as General Counsel

Cellares Announces Agreement with Kite to Evaluate Its Cell Shuttle Automated Manufacturing Platform

Gilead's Kite signs on with Cellares for cell therapy manufacturing test

Cellares enters into agreement with biopharma Kite

An automated approach to saving lives

Bristol Myers signs $380 mln CAR-T therapies supply deal with Cellares

Bristol Myers Squibb Signs $380 Million Deal With Cellares

An automated platform for cell therapy manufacturing, integrating technologies for all unit operations in a fully closed, automated, and high-throughput system.

Facilities equipped with Cell Shuttles for the mass manufacturing of cell therapies, designed to produce significantly more batches per year than conventional facilities.

A program offering cell therapy developers a way to automate and transfer their process onto the Cell Shuttle, aiming to accelerate process development for early-stage processes.

Services to optimize and automate cell therapy processes using standardized Cell Shuttle templates.

Automated and integrated analytical platform services for reliable in-process and final product characterization.

Manufacturing services using a global network of IDMO Smart Factories for all drug development and commercialization phases.

Bahrain

Asia

Thailand

Australia

Oceania

India

Equashield is a medical device company specializing in Closed System Transfer Devices (CSTDs) for safe handling of hazardous drugs.

Equashield

Cellares is the first Integrated Development and Manufacturing Organization (IDMO) that takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is developing and operating integrated technologies for cell therapy manufacturing to meet the total patient demand for cell therapies globally.

Sr. Director Supply Chain

Sr. Director, Supply Planning

Director, CAR-T Supply Planning

Global Brand Director

Director - Pediatric Vaccines

Associate Director

Technical Advisor

Project Scientist

Manufacturing Facilitator

Supply Chain Leader

Richard Bland

Director of Marketing

Senior Director, Commercial Marketing

Director of Strategic Marketing

Associate Director, Global Strategic Marketing | Clinical Oncology and Genomics

Global Market Development Manager | Clinical Oncology and Genomics

Global Product Line Manager | Genomics

Senior Manager, Marketing & Commercialization

Senior Marketing Manager

Director of Sales & Marketing

Global Product Manager

Technical Application Specialist

Associate Product Manager

Technical Sales Support Specialist

Research Associate III

Production Webmaster

DSL Technician

Research Assistant, High Throughput Screening Group

Biomedical Scientist

Lawreen Asuncion

Senior Director Information Technology

Director of Information Technology

Associate Director of GxP and R&D Application

Sr. System Analyst / DBA

Technical Application Manager

Head of Information Technology

Jack Wong

Chief Innovation Officer

Research Engineer

Co-Founder & CEO at Cellares - Hiring World Class Talent!

Director, Process Development

Director, Platform

Associate Director, Platform

Scientist, Test

Postdoctoral Research Associate, Chemical Engineering (Prather Lab)

Ph.D. Candidate, Civil & Environmental Engineering (Thompson Lab)

Director of Process Development at Cellares

Adam Freedman

Technical Product Owner

Product Owner

Senior Process Engineer

Process Engineer

Research Associate II

Manufacturing Associate

Student Intern

Technical Product Owner at Cellares

Director of Business Development & Academic Collaborations

Director of Product Management

Head Of Product Management

Principal Product Manager

Software Solutions

Product Strategy Consultant

Director, Automation Marketing

Sr. Product Manager

Improving access to life saving cell therapies.

Marc Beban

Director of Engineering

Sr. Director, Mechanical Engineering

Director of Mechanical Engineering

Senior Mechanical Engineer

Manager, Continuing Engineering

Mechanical Engineer

Sr. Design Engineer

Engineering Leader

Diane Brannigan

Director

Associate Director of Analytical Development

Manager of Analytical Development

Senior Scientist, Analytical Development, Process and Product Sciences

Senior Scientist, Analytical Development, BioTherapeutics (based in St. Louis, MO

Advanced Contingent Scientist, Analytical Development, BioTherapeutics

Research Associate

Assistant Specialist

Postdoctoral Fellow

Research Assoicate

PHD Student

Director at Cellares

Don Yuen

Director Of Information Technology

Sr. Member, IT Project Management

Senior IT Operations - Lead

Sr. Member, IT Operations

Director of Information Technology at Cellares

Kiran Kumar

Manager, MSAT

Senior MSAT and Operations Specialist

Supervisor, Manufacturing

Senior Manufacturing Associate

Senior Manufacturing Technician

Laboratory Technician

Research And Development Intern

Associate Director, MSAT at Cellares- - We're Hiring! Looking for World Class Scientists, Mechanical and Software Engineers.

Victoria Hodgson

Director, Software Applications

Manager, Software Applications

Sr. Manager, Software Engineering

Director Software Engineering

Senior Software Manager

Principal Engineer

Technical Lead

Software Engineering Leader | Technical Strategy | Architecture and Design | Talent Management and Recruiting

news impact assignment basic	general	Mar 3, 2024 10:53 PM	eb47398c
public peers	general
news daily refresh	general	Jul 25, 2024 12:00 PM	bbe5b0e7
news processing daily refresh	general	May 28, 2024 3:38 PM	b6ec8e42
news impact assignment daily	general	May 28, 2024 3:40 PM	c54722ad
news processing basic	general	Mar 3, 2024 10:53 PM	ffb6eb4b
company summary	general	May 28, 2024 3:43 PM	53dc003a
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	85a9e4e0
crunchbase profile	general	Nov 25, 2024 11:35 AM	237e39d0
li profile	general	Mar 3, 2024 10:53 PM	f5b67ffa
translate crunchbase fundingrounds	general	Nov 25, 2024 2:17 PM	44c5ce0b
peers	general
news basic	general	Mar 3, 2024 10:53 PM	15d15d0e
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:CELLARES

Cellares